Compared with the NAFLD+CAD group, the BMI, TG, LDL-C, HDL-C, ALT, and GGT of the NAFLD group were higher than those of the NAFLD+CAD group (all P < 0.05). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.